Literature DB >> 23616430

In non-small cell lung cancer mitogenic signaling leaves Sprouty1 protein levels unaffected.

Rosana Maria Kral1, Christoph-Erik Mayer, Vanita Vanas, Andrea Gsur, Hedwig Sutterlüty-Fall.   

Abstract

Sprouty1 protein belongs to a family of receptor tyrosine kinase-mediated signaling inhibitors, whose members are usually regulated by growth factors to form a negative feedback loop. Correspondingly fluctuations of Sprouty1 mRNA in response to single growth factors have been observed. In this report, we investigate Sprouty1 protein levels and show that in non-small cell lung carcinoma-derived cells, the expression levels are unaffected by the serum content in the cellular environment. Although cells harboring K-Ras mutations express insignificant higher Sprouty1 levels, ectopic expression of constitutive active Ras in normal human lung fibroblasts fails to augment Sprouty1 protein content. Furthermore, serum starvation for three days has no influence on Sprouty1 expression and addition of serum or of singular growth factors leaves Sprouty protein levels unchanged. Cell cycle analysis reveals that Sprouty1 levels remain constant throughout the whole cell cycle. These data demonstrate that Sprouty1 expression is not connected with mitogenic signaling and cell proliferation.
Copyright © 2013 John Wiley & Sons, Ltd.

Entities:  

Keywords:  NSCLC; Sprouty; Spry1; cell cycle

Mesh:

Substances:

Year:  2013        PMID: 23616430     DOI: 10.1002/cbf.2976

Source DB:  PubMed          Journal:  Cell Biochem Funct        ISSN: 0263-6484            Impact factor:   3.685


  8 in total

1.  Sprouty4 interferes with cell proliferation and migration of breast cancer-derived cell lines.

Authors:  Vanita Vanas; Elsa Mühlbacher; Rosana Kral; Hedwig Sutterlüty-Fall
Journal:  Tumour Biol       Date:  2014-01-09

2.  Sprouty4 mRNA variants and protein expressions in breast and lung-derived cells.

Authors:  Angelina Doriguzzi; Jihen Salhi; Hedwig Sutterlüty-Fall
Journal:  Oncol Lett       Date:  2016-09-30       Impact factor: 2.967

3.  The role of Sprouty1 in the proliferation, differentiation and apoptosis of epidermal keratinocytes.

Authors:  Ping Wang; Yuan Zhou; Jian-Qiang Yang; Lilla Landeck; Min Min; Xi-Bei Chen; Jia-Qi Chen; Wei Li; Sui-Qing Cai; Min Zheng; Xiao-Yong Man
Journal:  Cell Prolif       Date:  2018-07-23       Impact factor: 6.831

4.  A Sprouty4 Mutation Identified in Kallmann Syndrome Increases the Inhibitory Potency of the Protein towards FGF and Connected Processes.

Authors:  Astrid Stütz; Anna Z M Kamptner; Hedwig Sutterlüty
Journal:  Int J Mol Sci       Date:  2021-02-21       Impact factor: 5.923

5.  Sprouty3, but Not Sprouty1, Expression Is Beneficial for the Malignant Potential of Osteosarcoma Cells.

Authors:  Anna Zita Mehira Kamptner; Christoph-Erik Mayer; Hedwig Sutterlüty
Journal:  Int J Mol Sci       Date:  2021-11-04       Impact factor: 5.923

Review 6.  The developing story of Sprouty and cancer.

Authors:  Samar Masoumi-Moghaddam; Afshin Amini; David Lawson Morris
Journal:  Cancer Metastasis Rev       Date:  2014-09       Impact factor: 9.264

7.  MicroRNA-21 Increases Proliferation and Cisplatin Sensitivity of Osteosarcoma-Derived Cells.

Authors:  Vanita Vanas; Barbara Haigl; Verena Stockhammer; Hedwig Sutterlüty-Fall
Journal:  PLoS One       Date:  2016-08-11       Impact factor: 3.240

8.  Sprouty3 and Sprouty4, Two Members of a Family Known to Inhibit FGF-Mediated Signaling, Exert Opposing Roles on Proliferation and Migration of Glioblastoma-Derived Cells.

Authors:  Burcu Emine Celik-Selvi; Astrid Stütz; Christoph-Erik Mayer; Jihen Salhi; Gerald Siegwart; Hedwig Sutterlüty
Journal:  Cells       Date:  2019-08-01       Impact factor: 6.600

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.